SHE, 301281 End of Day and Historical Stock Data []

The worlds #1 website for end of day & historical stock data

wide range of exchanges, data formats, tools and services

APINEW HISTORICAL DATA SYMBOL LISTS MEMBERSHIP REGISTER LOG IN

SHE, 301281: Shandong Keyuan Pharmaceutical Co. Ltd. A

27 Aug 2025

LAST: 35.62	CHANGE: 1.59	OPEN: 37.22	HIGH: 37.25	ASK: 0.00	VOLUME: 3.38M
LAST: 35.62	CHG(%): 4.27	PREV: 37.21	LOW: 35.61	BID: 0.00

CHART

Period:

RECENT END OF DAY PRICES

Date	Open	High	Low	Close	Volume
27 Aug 25	37.22	37.25	35.61	35.62	3.38M
26 Aug 25	36.90	37.83	36.61	37.21	3.06M
25 Aug 25	36.80	37.18	36.51	36.96	3.38M
22 Aug 25	38.33	38.53	36.78	36.87	4.36M
21 Aug 25	36.93	37.72	36.58	37.34	3.8M
20 Aug 25	36.96	37.23	36.27	36.88	3.32M
19 Aug 25	37.76	38.20	36.88	37.35	4.76M
18 Aug 25	36.78	37.48	36.30	37.29	5.85M
15 Aug 25	35.45	35.82	35.20	35.82	2.24M
14 Aug 25	36.06	36.65	35.14	35.24	3.22M

COMPANY PROFILE

Name:	Shandong Keyuan Pharmaceutical Co. Ltd. A
About:	Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of active pharmaceutical ingredients. It offers gliclazide, for the treatment of NIDDM; metformin hydrochloride used as an adjunct to diet and exercise in adult patients with NIDDM; isosorbide mononitrate for prevention of angina pectoris and treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction; isosorbide dinitrate to prevent angina pectoris due to coronary artery disease; mecobalamin for peripheral neuropathies; lansoprazole to treat acid-reflux disorders, peptic ulcer disease, h. pylori eradication, and prevention of gastrointestinal bleeds; ropivacaine hydrochloride for obstetric and regional anesthesia; isoflurane; fluoxetine hydrochloride, an anti-depression drug; clemastine fumarate, an anti-allergic agent; isoprenaline hydrochloride to treat mild or transient episodes of heart block; esmolol hydrochloride for the rapid control of ventricular rate; xanthinol nicotinate to treat of brain function barrier, cerebral embolism and cerebral thrombosis; amlexanox for treatment of aphthous ulcers; nisolsipine for hypertension; clarithromycin lactobionate; trepibutone; propafenone hydrochloride; diclofenac potassium to treat osteoarthritis and rheumatoid arthritis; chlorzoxazone for relief of discomfort associated with acute painful musculoskeletal conditions; esomeprazole sodium treats related gastric ulcer disease and zollinger-ehrlich syndrome; palonosetron hydrochloride, a chemotherapy adjuvant medication; edaravone, a cerebral protective agent; vildagliptin to treat diabetes; etamsylate, a hemostatic medication; pranoprofen that is a non-steroidal anti-inflammatory analgesic and antipyretic drugs; parecoxib sodium; and lurasidone hydrochloride, a medication for schizophrenia. The company was incorporated in 2004 and is headquartered in Jinan, China.
Sector:	Healthcare
Address:	Keyuan Street, Jinan, China, 251601
Website:	https://www.keyuanpharm.com
ISIN:	CNE1000061V8

SYMBOL HISTORY

Purchase End of Day History
for this symbol from Jan 01, 0001

Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

Exchange:

Format:

Period:

Zip file

Symbol:

Start Date:

End Date:

FUNDAMENTALS

P/E Ratio:	59.19
DivYield:	0.01
Div/Share:	0.20
PtB:	2.89
PtS:	8.75
EBITDA:	101.21M
Shares:	108.29M
Market Cap:	3.857B

TECHNICAL INDICATORS

MA5:	36.80
MA10:	36.66
MA20:	36.74
MA50:	34.64
MA100:	33.08
MA200:	32.96
STO14:	11.55
RSI14:	46.67
WPR14:	-81.99
MTM14:	-0.11
ROC14:	0.00
ATR:	1.19
Week High:	38.53
Week Low:	35.61
Month High:	41.01
Month Low:	35.14
Year High:	58.66
Year Low:	18.52